CHRU de Brest
Brest, 29609, France
NCT Number: NCT03686670
The study goal is to determine the feasbility and interest of monitoring mental health and non mental health related simptoms in Outpatients in order to prevent suicide.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Brest, 29609, France
Taking into account the strengths and pitfalls of existing suicide risk assessment methods, we have designed a system capable to combine EMA and continuous monitoring of patients using the smartphone's and/or wearable's sensors and data entry in order to monitor and predict suicide risk. For example, both poor sleep quality and disturbed appetite are clinical markers of depression, with a bidirectional relationship. Their changes could precede the increase of suicidal behavior as sleep and appetite are both influenced by mood state and regulated by the serotonergic system. Our hypothesis is that tracking mental health simptoms regularly through self-report could serve as a consistent and non-biased shortcut to assess mood state, its biological underpinnings and could potentially predict suicidal behavior.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
To be eligible for the study, patients must be 18 years or older, attend an outpatient clinic or emergency departments of participating clinical services and owning an android or IOS smartphone
Time frame: 2 month
acceptability assessed by the AES scale
University Hospital, Brest
Other
Acceptability Study SMARTphone to Collect Clinical Data Using the Memind App by Patients and Medical Satff.
Acronym: MeMind
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05282225
Behavior, Behavioral Symptoms
Ann Arbor, Michigan, United States
View Trial DetailsNCT05397353
Behavior, Behavioral Symptoms
Piscataway, New Jersey, United States
View Trial DetailsNCT06406972
Behavior, Behavioral Symptoms
Lund, Skåne County, Sweden
View Trial DetailsNCT03894462
Behavior, Behavioral Symptoms
Rochester, New York, United States
View Trial Details